Zamicastat

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameZamicastat
Drug Alias NameZamicastatum扎卡司他扎米司他BIA-5-1058
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine beta-hydroxylase inhibitors
TargetsDopamine beta-hydroxylase
Therapy Area/IndicationsHeart FailureCardiovascular DiseasesPulmonary Arterial Hypertension +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkrainePortugalNetherlands +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBial-Portela
China Registration ClassN/A

Develop Information

Active CompaniesBial - Portela C Sa
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsHeart FailureCardiovascular DiseasesLung Diseases

Other Information

ATC CodeN/A
Related LinksN/A